Xencor (XNCR) Capital Expenditures Growth (1y) (2014 - 2026)
Xencor (XNCR) Capital Expenditures Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Xencor |
953.38 Mn |
878.64 Mn |
- |
-57.76% |
| Date | Value |
|---|
| Mar 31, 2026 |
-57.76% |
| Dec 31, 2025 |
-31.49% |
| Sep 30, 2025 |
-85.65% |
| Jun 30, 2025 |
-87.34% |
| Mar 31, 2025 |
993.94% |
| Dec 31, 2024 |
69.80% |
| Sep 30, 2024 |
-54.98% |
| Jun 30, 2024 |
-21.46% |
| Mar 31, 2024 |
-98.78% |
| Dec 31, 2023 |
-90.17% |
| Sep 30, 2023 |
-79.89% |
| Jun 30, 2023 |
-68.81% |
| Mar 31, 2023 |
416.18% |
| Dec 31, 2022 |
57.69% |
| Sep 30, 2022 |
413.11% |
| Jun 30, 2022 |
441.13% |
| Mar 31, 2022 |
7.07% |
| Dec 31, 2021 |
100.70% |
| Sep 30, 2021 |
-41.53% |
| Jun 30, 2021 |
267.04% |
